430 related articles for article (PubMed ID: 26134114)
1. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
[TBL] [Abstract][Full Text] [Related]
2. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
Kim SU; Heo JY; Kim BK; Park JY; Kim DY; Han KH; Ahn SH; Kim HS
Liver Int; 2017 Jun; 37(6):879-887. PubMed ID: 27973711
[TBL] [Abstract][Full Text] [Related]
3. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
Sasaki R; Yamasaki K; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Bekki S; Kugiyama Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Ichikawa T; Nakao K; Yatsuhashi H
PLoS One; 2015; 10(6):e0129053. PubMed ID: 26070204
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
[TBL] [Abstract][Full Text] [Related]
5. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Kim HS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Park YN; Han DH; Kim KS; Choi JS; Choi GH; Kim HS
Clin Mol Hepatol; 2020 Jan; 26(1):33-44. PubMed ID: 31243939
[TBL] [Abstract][Full Text] [Related]
6. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.
Kawaguchi K; Honda M; Ohta H; Terashima T; Shimakami T; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Komura T; Unoura M; Kaneko S
J Gastroenterol; 2018 Jun; 53(6):740-751. PubMed ID: 28849280
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein.
Sato S; Genda T; Ichida T; Amano N; Sato S; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Hirano K; Shimada Y; Iijima K; Wada R; Nagahara A; Watanabe S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999409
[TBL] [Abstract][Full Text] [Related]
8. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
Heo JY; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YN; Ahn SS; Han KH; Kim HS
Medicine (Baltimore); 2016 Apr; 95(14):e3328. PubMed ID: 27057911
[TBL] [Abstract][Full Text] [Related]
9. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis.
Xu WP; Wang ZR; Zou X; Zhao C; Wang R; Shi PM; Yuan ZL; Yang F; Zeng X; Wang PQ; Sultan S; Zhang Y; Xie WF
J Dig Dis; 2018 Apr; 19(4):242-253. PubMed ID: 29607614
[TBL] [Abstract][Full Text] [Related]
10. Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA
Inoue T; Tsuzuki Y; Iio E; Shinkai N; Matsunami K; Fujiwara K; Matsuura K; Nojiri S; Tanaka Y
Jpn J Infect Dis; 2018 May; 71(3):177-183. PubMed ID: 29491234
[TBL] [Abstract][Full Text] [Related]
11. Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.
Okada A; Kanzaki H; Hamatani Y; Takashio S; Takahama H; Amaki M; Hasegawa T; Sugano Y; Yasuda S; Anzai T
Heart Vessels; 2018 Apr; 33(4):385-392. PubMed ID: 29098408
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis.
Kono M; Nakamura Y; Oyama Y; Mori K; Hozumi H; Karayama M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Yamada M; Hamada E; Colby TV; Maekawa M; Suda T
Respir Med; 2016 Jun; 115():46-52. PubMed ID: 27215503
[TBL] [Abstract][Full Text] [Related]
13. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
[TBL] [Abstract][Full Text] [Related]
14. Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis.
Uojima H; Hidaka H; Tanaka Y; Inoue T; Onoue M; Wada N; Kubota K; Nakazawa T; Shibuya A; Fujikawa T; Nakayama T; Yamanoue H; Sung JH; Kako M; Koizumi W
J Gastroenterol Hepatol; 2018 Nov; 33(11):1889-1896. PubMed ID: 29737582
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Level in Early Stage Hepatocellular Carcinoma.
Lin J; Ko CJ; Hung YJ; Lin PY; Lin KH; Hsieh CE; Chou CT; Chen YL
Sci Rep; 2020 Mar; 10(1):5651. PubMed ID: 32221384
[TBL] [Abstract][Full Text] [Related]
16. A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements.
Lin YJ; Chang CL; Chen LC; Hu HH; Liu J; Korenaga M; Huang YH; Jen CL; Su CY; Nishida N; Sugiyama M; Lu SN; Wang LY; Yuan Y; L'Italien G; Yang HI; Mizokami M; Chen CJ; Lee MH
Clin Transl Gastroenterol; 2018 Sep; 9(9):183. PubMed ID: 30237482
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
Yamasaki K; Tateyama M; Abiru S; Komori A; Nagaoka S; Saeki A; Hashimoto S; Sasaki R; Bekki S; Kugiyama Y; Miyazoe Y; Kuno A; Korenaga M; Togayachi A; Ocho M; Mizokami M; Narimatsu H; Yatsuhashi H
Hepatology; 2014 Nov; 60(5):1563-70. PubMed ID: 25042054
[TBL] [Abstract][Full Text] [Related]
18. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
Alkhouri N; Johnson C; Adams L; Kitajima S; Tsuruno C; Colpitts TL; Hatcho K; Lawitz E; Lopez R; Feldstein AE
PLoS One; 2018; 13(8):e0202226. PubMed ID: 30161179
[TBL] [Abstract][Full Text] [Related]
19. Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C.
Nagata H; Nakagawa M; Asahina Y; Sato A; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Nouchi T; Sakai H; Tomita M; Watanabe M;
J Hepatol; 2017 Nov; 67(5):933-939. PubMed ID: 28627363
[TBL] [Abstract][Full Text] [Related]
20. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.
Ura K; Furusyo N; Ogawa E; Hayashi T; Mukae H; Shimizu M; Toyoda K; Murata M; Hayashi J
Aliment Pharmacol Ther; 2016 Jan; 43(1):114-24. PubMed ID: 26503582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
